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Background: Heterotopic pancreas is defined as finding of pancreatic tissue without anatomic and vascular
continuity with the normal pancreas. Heterotopic pancreas is a rare condition difficult to diagnose and with
controversial clinical management.
Case presentation: We describe a 43 year old female patient previously submitted to laparoscopic gastric bypass
for primary treatment of morbid obesity; 5 years later, the patient was discovered to have a mass in the antrum of
the excluded stomach that was found to be heterotopic pancreatic tissue. Before gastric bypass surgery, the
presence of the pancreatic mass in the gastric wall was unnoticed in the imagiologic records.
Conclusion: This is the first reported case of pancreatic heterotopy diagnosed in the excluded stomach after
gastric bypass. A putative role of incretin hormones in mediating pancreatic cell hyperplasia of heterotopic
pancreatic remnants should be considered an additional hypothesis that requires further research.
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Heterotopic pancreas was first described in 1727 by
Schultz and is defined as the presence of pancreatic tissue
whithout anatomic and vascular continuity with the normal
pancreas [1]. It is found in 0.55-15% of autopsy specimens
[2] being more common at the age of 30–50 years with a
male predominance [3]. The heterotopic tissue can be
found anywhere from the distal end of the esophagus to
the colon, but mostly occurs in upper gastrointestinal
tract: stomach(25%), duodenum(30%) and jejunum(15%),
but also in liver, gallbladder, distal small intestine, colon,
appendix, omentum, fallopian tube, common bile duct,
cystic duct, ampulla of Vater, spleen, lymph nodes and
Meckel’s diverticula. Extra-abdominal sites included
mediastinal cysts, bronchi, lung, umbilicus and brain
[4-8]. The most common heterotopic site is the stomach
(25-40%), especially antrum and prepyloric region on
the greater curvature or posterior wall [9].* Correspondence: mpmonteiro@icbas.up.pt
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reproduction in any medium, provided the orHeterotopic pancreas is thought to take place when
the foregut rotates between weeks 5 and 8 of gestation,
while pancreatic fragments detach from the pancreas and
are deposited ectopically [10]. Heterotopic pancreatic tissue
in the gastro-intestinal tract generally occurs as discrete
firm, irregular, yellow nodules located in the submucosa.
Histologically heterotopic pancreatic tissue is not a true
neoplasm but rather a hamartoma of fat glandular tissue
with pancreatic acinar formation and duct development
[8]. In the majority of cases the patients are asymptomatic
and the condition is incidentally discovered [11]. Almost
all changes which can occur in the pancreas itself may de-
velop in heterotopic pancreas [12], although malignant
transformation is extremely rare [10].
There are several cases of heterotopic pancreases
described in the literature, but to date none of them was
diagnosed in the excluded stomach after gastric bypass.
Case presentation
A 43 years old female patient was previously submitted to
laparoscopic gastric bypass for morbid obesity without
co-morbidities. Seven months after the bariatric surgery
the patient showed intense episodic epigastric abdominal
pain that was aggravated by food ingestion and led to
multiple visits to the emergency room.tral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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patient was offered hospital admission for further evalu-
ation. Physical examination was unremarkable and routine
blood assessment of liver and pancreatic functions were
normal. The upper endoscopy and esophageal-gastro-jejunal
transit were normal; the abdominal CT and MRI were
considered normal despite the presence of a mass in the
excluded stomach, as it was ascribed to the anatomical
rearrangement after the bypass surgery (Figure 1A). During
hospital stay the patient did present any evidence of
abdominal pain, complaints or need for analgesia; after
formal psychiatric evaluation, a major depression was
diagnosed and the patient was started on anti-depressants.
Five years after gastric bypass, due to ongoing epigastric
pain complaints, abdominal CT and MRI were repeated,
with subsequent diagnosis of a 4.5 cm of greater diameter
subserosal neoplasm in the antrum (Figure 1B).
The patient underwent laparoscopic gastrectomy of the
excluded stomach for suspected gastrointestinal stromal
tumor (GIST) (Figure 2A). Gross examination of the
specimen revealed a subserosal polypoid mass in the gas-
tric antrum, which corresponded to a 4.5 cm cystic cavityFigure 1 Abdominal MRI shortly after (A) and 5 years after
gastric bypass (B) displaying the subserosal mass in the gastric
antrum (arrows), the former previously unnoticed.of greater diameter with creamy yellowish thick content,
growing in dependency of the gastric muscular layer
(Figure 2B). The histology of the mass showed a flap
of gastric wall with antral mucosa and a heterotopic
pancreatic cist, while in the adipose tissue of the root
of the greater omentum six other yellow and lobulated
nodules were identified and dissected. All fragments
corresponded histologicaly to pancreatic tissue with nor-
mal exocrine and endocrine distribution, as displayed by
the immunohistochemistry staining for chromogranin A,
insulin and glucagon expressing cells, as well as a low pro-
liferation index as revealed by the Ki-67 staining, which
are characteristic of the normal pancreatic tissue (Figure 3,
A-F). After gastrectomy, the patient became asymptomatic
and so has remained ever since.
Discussion
Most patients with heterotopic pancreas are asymptomatic;
when present, the reported symptoms include abdominal
pain, epigastric discomfort, bleeding, nausea and vomiting;
sometimes symptoms are related to complications, such
as mechanical occlusion - intussusceptions and obstruction
of the small bowel, obstructive jaundice and pyloric
stenosis [8,13]. Other complications include: pancreatitis,
pseudocyst formation, carcinomas, islet-cell tumors and
inflammatory pseudotumors [6]. Most cases of gastric het-
erotopic pancreas are incidental findings during surgery,
gastrointestinal exam or autopsy.
The differential diagnosis includes GIST, gastrointestinal
autonomic nerve tumor (GANT), carcinoid, lymphoma or
gastric carcinoma which can be misinterpreted on imaging
studies or endoscopic examinations [14,15].
Since heterotopic pancreas is an uncommon condition,
unlike GIST, it is rarely considered a diagnostic hypothesis.
Five CT features were pointed as significant predictors
in the differential diagnosis of heterotopic pancreas from
GIST and leiomyomas, namely: 1) prominent enhancement
of the overlying mucosa, 2) location, 3) long diameter/short
diameter ratio of the lesion, 4) growth pattern and 5) lesion
border [16]. At endoscopy the heterotopic pancreas
generally appears as a well-defined dome-shaped filling
defect with central umbilication. Definitive diagnosis
requires histological confirmation.
Management of this condition is controversial. Most
cases undergo surgery due to diagnostic uncertainty.
Reasons for surgical treatment depend on the presence
of symptoms, as well as need of definitive diagnosis,
excluding malignancy or avoiding complications [17].
This patient had both normal abdominal ultrasound
and gastroduodenoscopy before gastric bypass¸ and the
presence of a mass in the excluded stomach had been
unnoticed in the abdominal CT and MRI performed four
years before gastrectomy. In the herein case presented,
GIST of the excluded stomach was the first diagnostic
Figure 2 Macroscopic appearance of the subserosal mass at laparoscopy (A) and in the excluded stomach removed after partial
gastrectomy (white arrows) (B).
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endoscopic ultra-sound (EUS) could not be useful.
There was no evidence of acute pancreatitis in any
recurrency of episodic abdominal pain that lead patient
to visit the emergency room, as suggested from serum
amylase and lipase levels, however, since the heterotopic
pancreas included a cystic cavity with a thick liquid content,
the formation of a cyst in result of retention of exocrine
secretions in the absence of communication between
the glandular epithelium and the gastric lumen cannot
be excluded.Figure 3 Histology of the muscular gastric wall and the normal heter
the omentum (B), with respective imunostaining for the neuro-endoc
showing normal exocrine pancreas and Langerhans islets, with norm
glucagon expressing cells; the proliferation index was also normally l
in brown).Gastric bypass is known to induce changes in the secre-
tion of insulinotropic enteric hormones, which may be in-
volved in metabolic changes, remission of diabetes mellitus
[18,19] and have a role in inducing pancreatic exocrine and
endocrine cell proliferation [20]. Thus, it is conceivable
that microscopic heterotopic nodules of pancreatic tissue
can grow in result of gastric bypass surgery, similarly
to what has been hypothesized to occur with regards to
orthotic pancreatic tissue. Notwithstanding, the action of
incretin hormones in stimulation the growth of pancreatic
tissue still needs further research.otopic pancreatic tissue in the subserosa (A) and tissue nodule in
rine markers chromogranin A (C), insulin (D) and glucagon (E),
al distribution of neuroendocrine cells, as well as insulin and
ow as displayed by the Ki-67 staining (F) (immune staining
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Heterotopic pancreas is a rare condition, difficult to
diagnose and with controversial management. We present
the first case of pancreatic heterotopy diagnosed after
gastric bypass surgery. The role of incretin hormones in
stimulating the growth of pancreatic cells and its conse-
quences justifies further investigation.
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